相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。T-cell exhaustion and stemness in antitumor immunity: Characteristics, mechanisms, and implications
Xiaoxia Chi et al.
FRONTIERS IN IMMUNOLOGY (2023)
Roles of natural killer cells in immunity to cancer, and applications to immunotherapy
Natalie K. Wolf et al.
NATURE REVIEWS IMMUNOLOGY (2023)
New Checkpoint Inhibitors on the Road: Targeting TIM-3 in Solid Tumors
Ana Luiza Gomes de Morais et al.
CURRENT ONCOLOGY REPORTS (2022)
A PD-L1 and VEGFR2 dual targeted peptide and its combination with irradiation for cancer immunotherapy
Ling Jiao et al.
PHARMACOLOGICAL RESEARCH (2022)
Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance
Sreya Bagchi et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 16, 2021 (2021)
Identification of Phelligridin-Based Compounds as Novel Human CD73 Inhibitors
Sifan Lyu et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2021)
Immune checkpoint inhibitors in melanoma
Matteo S Carlino et al.
LANCET (2021)
TIM-3 restrains anti-tumour immunity by regulating inflammasome activation
Karen O. Dixon et al.
NATURE (2021)
Targeting Tim-3 in Cancer With Resistance to PD-1/PD-L1 Blockade
Tian Tian et al.
FRONTIERS IN ONCOLOGY (2021)
Tim-3 Hampers Tumor Surveillance of Liver-Resident and Conventional NK Cells by Disrupting PI3K Signaling
Siyu Tan et al.
CANCER RESEARCH (2020)
A Novel d-Peptide Identified by Mirror-Image Phage Display Blocks TIGIT/PVR for Cancer Immunotherapy
Xiuman Zhou et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
Blocking immunosuppressive neutrophils deters pY696-EZH2-driven brain metastases
Lin Zhang et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Tim-3 finds its place in the cancer immunotherapy landscape
Nandini Acharya et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
The biologically functional identification of a novel TIM3-binding peptide P26 in vitro and in vivo
Tangwu Zhong et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2020)
Identification and characterization of M6903, an antagonistic anti-TIM-3 monoclonal antibody
Dong Zhang et al.
ONCOIMMUNOLOGY (2020)
TIM3 comes of age as an inhibitory receptor
Yochai Wolf et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Blockade of Tim-3 binding to phosphatidylserine and CEACAM1 is a shared feature of anti-Tim-3 antibodies that have functional efficacy
Catherine A. Sabatos-Peyton et al.
ONCOIMMUNOLOGY (2018)
TIM-3 Regulates CD103(+) Dendritic Cell Function and Response to Chemotherapy in Breast Cancer
Alvaro de Mingo Pulido et al.
CANCER CELL (2018)
High resolution X-ray and NMR structural study of human T-cell immunoglobulin and mucin domain containing protein-3
Amit K. Gandhi et al.
SCIENTIFIC REPORTS (2018)
Tim-3 and its role in regulating anti-tumor immunity
Madhumita Das et al.
IMMUNOLOGICAL REVIEWS (2017)
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma et al.
CELL (2017)
Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints
Shohei Koyama et al.
NATURE COMMUNICATIONS (2016)
Tim-3 promotes tumor-promoting M2 macrophage polarization by binding to STAT1 and suppressing the STAT1-miR-155 signaling axis
Xingwei Jiang et al.
ONCOIMMUNOLOGY (2016)
Apoptosis of tumor infiltrating effector TIM-3+CD8+T cells in colon cancer
Chiao-Wen Kang et al.
SCIENTIFIC REPORTS (2015)
CEACAM1 regulates TIM-3-mediated tolerance and exhaustion
Yu-Hwa Huang et al.
NATURE (2015)
Molecular and cellular insights into T cell exhaustion
E. John Wherry et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity
Lishomwa C. Ndhlovu et al.
BLOOD (2012)
Allograft rejection is restrained by short-lived TIM-3+PD-1+Foxp3+ Tregs
Shipra Gupta et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1
Shigeki Chiba et al.
NATURE IMMUNOLOGY (2012)
Bat3 promotes T cell responses and autoimmunity by repressing Tim-3-mediated cell death and exhaustion
Manu Rangachari et al.
NATURE MEDICINE (2012)
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
Kaori Sakuishi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Premature Terminal Exhaustion of Friend Virus-Specific Effector CD8+ T Cells by Rapid Induction of Multiple Inhibitory Receptors
Shiki Takamura et al.
JOURNAL OF IMMUNOLOGY (2010)
T Cell/Transmembrane, Ig, and Mucin-3 Allelic Variants Differentially Recognize Phosphatidylserine and Mediate Phagocytosis of Apoptotic Cells
Rosemarie H. DeKruyff et al.
JOURNAL OF IMMUNOLOGY (2010)
Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation
Masafumi Nakayama et al.
BLOOD (2009)
The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity
C Zhu et al.
NATURE IMMUNOLOGY (2005)
分享论文
